A large-scale study demonstrates that high-resolution KIR gene profiling is crucial for selecting the optimal hematopoietic stem cell donors, significantly enhancing patient outcomes beyond traditional HLA matching.
Most Recent Articles
AI-Powered OCT Analysis Predicts Adverse Cardiovascular Events More Accurately Than Manual Interpretation
A new study demonstrates that an artificial intelligence algorithm can analyze intravascular images to predict recurrent heart attacks more accurately than human experts, paving the way for automated cardiovascular risk...
REBOOT Trial Analysis Reveals Sex-Specific Harm of Beta-Blockers Post-MI in Women
A major clinical trial reveals that beta-blocker therapy after a heart attack may be harmful to women with preserved heart function, challenging standard treatment guidelines.
AI-Enabled Stethoscope Increases Cardiac Diagnoses in Primary Care: Findings from the TRICORDER Trial
A landmark UK trial demonstrates that an AI-enabled stethoscope can more than double the detection rate of heart failure in primary care, enabling earlier diagnosis and treatment for patients.
REBOOT Trial: Beta-Blockers Show No Benefit Post-MI in Patients with Preserved Ejection Fraction
The REBOOT trial finds beta-blockers offer no benefit after uncomplicated heart attacks with preserved cardiac function, challenging a decades-old treatment paradigm and suggesting a need to update clinical guidelines.